PMID- 37092860 OWN - NLM STAT- MEDLINE DCOM- 20230517 LR - 20230520 IS - 1745-7270 (Electronic) IS - 1672-9145 (Print) IS - 1672-9145 (Linking) VI - 55 IP - 4 DP - 2023 Apr 19 TI - Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells. PG - 587-600 LID - 10.3724/abbs.2023068 [doi] AB - Ginsenoside Rh3 (GRh3) is a seminatural product obtained by chemical processing after isolation from Chinese herbal medicine that has strong antitumor activity against human tumors. However, its antitumor role remains to be elucidated. The aim of this study is to explore the mechanisms underlying the tumor suppressive activity of GRh3 from the perspective of pyroptosis and ferroptosis. GRh3 eliminates colorectal cancer (CRC) cells by activating gasdermin D (GSDMD)-dependent pyroptosis and suppressing solute carrier family 7 member 11 (SLC7A11), resulting in ferroptosis activation through the Stat3/p53/NRF2 axis. GRh3 suppresses nuclear factor erythroid 2-related factor 2 (NRF2) entry into the nucleus, leading to the decrease of heme oxygenase 1 (HO-1) expression, which in turn promotes NOD-like receptor thermal protein domain associated protein 3 (NLRP3) and caspase-1 expression. Finally, caspase-1 activates GSDMD-dependent pyroptosis. Furthermore, GRh3 prevents NRF2 from entering the nucleus, which suppresses SLC7A11, causing the depletion of glutathione (GSH) and accumulation of iron, lipid reactive oxygen species (ROS) and malondialdehyde (MDA), and eventually leading to ferroptosis in CRC cells. In addition, GRh3 effectively inhibits the proliferation of CRC cells in vitro and in nude mouse models. Collectively, GRh3 triggers pyroptotic cell death and ferroptotic cell death in CRC cells via the Stat3/p53/NRF2 axis with minimal harm to normal cells, showing great anticancer potential. FAU - Wu, Yingchao AU - Wu Y AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Pi, Dajin AU - Pi D AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Zhou, Shuyao AU - Zhou S AD - College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510642, China. FAU - Yi, Zhongjia AU - Yi Z AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Dong, Yangyang AU - Dong Y AD - Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China. FAU - Wang, Wuhong AU - Wang W AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Ye, Huan AU - Ye H AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Chen, Yiliu AU - Chen Y AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. FAU - Zuo, Qian AU - Zuo Q AD - MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. FAU - Ouyang, Mingzi AU - Ouyang M AD - School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. LA - eng PT - Journal Article PL - China TA - Acta Biochim Biophys Sin (Shanghai) JT - Acta biochimica et biophysica Sinica JID - 101206716 RN - 105558-26-7 (ginsenoside Rh3) RN - 0 (NF-E2-Related Factor 2) RN - 0 (Tumor Suppressor Protein p53) RN - EC 3.4.22.36 (Caspase 1) RN - GAN16C9B8O (Glutathione) RN - 0 (STAT3 protein, human) RN - 0 (STAT3 Transcription Factor) SB - IM MH - Humans MH - Animals MH - Mice MH - Pyroptosis MH - NF-E2-Related Factor 2/genetics MH - Tumor Suppressor Protein p53 MH - *Ferroptosis MH - Caspase 1 MH - Glutathione MH - Mice, Nude MH - *Colorectal Neoplasms/drug therapy MH - STAT3 Transcription Factor PMC - PMC10195137 OTO - NOTNLM OT - Stat3/p53/NRF2 axis OT - colorectal cancer OT - ferroptosis OT - ginsenoside Rh3 OT - pyroptosis COIS- The authors declare that they have no conflict of interest. EDAT- 2023/04/24 12:42 MHDA- 2023/05/17 06:42 PMCR- 2023/04/19 CRDT- 2023/04/24 09:13 PHST- 2023/05/17 06:42 [medline] PHST- 2023/04/24 12:42 [pubmed] PHST- 2023/04/24 09:13 [entrez] PHST- 2023/04/19 00:00 [pmc-release] AID - 10.3724/abbs.2023068 [doi] PST - ppublish SO - Acta Biochim Biophys Sin (Shanghai). 2023 Apr 19;55(4):587-600. doi: 10.3724/abbs.2023068.